Drug intelligence / Profile preview

Systane Balance

Development stage: Unknown
Lead developer: Alcon
Modality: Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
Administration: Ophthalmic

Overview

Systane Balance is a lubricant eye drop product designed to provide relief for dry eyes, particularly for those with Meibomian Gland Dysfunction (MGD). It contains propylene glycol as its active ingredient and works by restoring the eye's lipid layer to minimize moisture loss due to evaporation. Systane Balance has a unique milky white appearance due to its mineral oil and phospholipid content, requiring users to shake the bottle before application. It's formulated specifically to support and restore the eye's delicate lipid layer, which helps prevent tear evaporation and provides lasting relief from moderate to severe dry eye symptoms.

Brand names: Systane Balance

Beyond the preview

Go deeper on Systane Balance.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Systane Balance.

Explore the full profile